SEARCH

SEARCH BY CITATION

References

  • 1
    Mitra AK, Faruque FS. Breast cancer incidence and exposure to environmental chemicals in 82 counties in Mississippi. South Med J 2004; 97: 25963.
  • 2
    Brody JG, Rudel RA. Environmental pollutants and breast cancer. Environ Health Perspect 2003; 111: 100719.
  • 3
    Wang AM, Sha SH, Lesniak W, Schacht J. Tanshinone (Salviae miltiorrhizae extract) preparations attenuate aminoglycoside-induced free radical formation in vitro and ototoxicity in vivo. Antimicrob Agents Chemother 2003; 47: 183641.
  • 4
    Niu XL, Ichimori K, Yang X, Hirota Y, Hoshiai K, Li M, Nakazawa H. Tanshinone II-A inhibits low-density lipoprotein oxidation in vitro. Free Radic Res 2000; 33: 30512.
  • 5
    Zhou GY, Zhao BL, Hou JW, Ma GE, Xin WJ. Protective effects of sodium tanshinone IIA sulphonate against Adriamycin-induced lipid peroxidation in mice hearts in vivo and in vitro. Pharmacol Res 1999; 40: 48791.
  • 6
    Cao EH, Liu XQ, Wang JJ, Xu NF. Effect of natural antioxidant tanshinone II-A on DNA damage by lipid peroxidation in liver cells. Free Radic Biol Med 1996; 20: 8016.
  • 7
    Wu WL, Chang WL, Chen CF. Cytotoxic activities of tanshinones against human carcinoma cell lines. Am J Chin Med 1991; 19: 20716.
  • 8
    Mosaddik MA. In vitro cytotoxicity of tanshinones isolated from Salvia miltiorrhiza Bunge against P388 lymphocytic leukemia cells. Phytomedicine 2003; 10: 6825.
  • 9
    Wang X, Yuan S, Huang R, Song Y. An observation of the effect of tanshinone on cancer cell proliferation by Brdu and PCNA labeling. Hua Xi Yi Ke Da Xue Xue Bao 1996; 27: 38891.
  • 10
    Tang Z, Tang Y, Fu L. Growth inhibition and apoptosis induction in human hepatoma cells by tanshinone II A. J Huazhong Univ Sci Technolog Med Sci 2003; 23: 1668.
  • 11
    Tang ZZ, Tang Y, Fu LB. Effect of tanshinone IIA on the growth behavior of human hepatoma cell line BEL-7402 in vitro and its mechanism. Di Yi Jun Yi Da Xue Xue Bao 2003; 23: 5957.
  • 12
    Yuan SL, Wei YQ, Wang XJ, Xiao F, Li SF, Zhang J. Growth inhibition and apoptosis induction of tanshinone IIA on human hepatocellular carcinoma cells. World J Gastroenterol 2004; 10: 20248.
  • 13
    Sung HJ, Choi SM, Yoon Y, An KS. Tanshinone IIA, an ingredient of Salvia miltiorrhiza Bunge, induces apoptosis in human leukemia cell lines through the activation of caspase-3. Exp Mol Med 1999; 31: 1748.
  • 14
    Yoon Y, Kim YO, Jeon WK, Park HJ, Sung HJ. Tanshinone IIA isolated from Salvia miltiorrhiza Bunge induced apoptosis in HL60 human premyelocytic leukemia cell line. J Ethnopharmacol 1999; 68: 1217.
  • 15
    Liang Y, Yang Y, Yuan S, Liu T, Jia Y, Xu C, Niu T, Qin H, Qin P. Terminal differentiation of human acute promyelocytic leukemia (APL) cells induced by tanshinone II A in primary culture. Hua Xi Yi Ke Da Xue Xue Bao 2000; 31: 20710.
  • 16
    Wu Y, Yang Y, Meng W, Li Y, Jia Y, Liu T. Study on the differentiation of K562 cell-line induced by tanshinone II A. Hua Xi Yi Ke Da Xue Xue Bao 2002; 33: 803.
  • 17
    Wang ZY. Ham-Wassermann lecture. Treatment of acute leukemia by inducing differentiation and apoptosis. Hematology (Am Soc Hematol Educ Program) 2003; 1: 113.
  • 18
    Wang X, Yuan S, Wang C. A preliminary study of the anti-cancer effect of tanshinone on hepatic carcinoma and its mechanism of action in mice. Zhonghua Zhong Liu Za Zhi 1996; 18: 4124.
  • 19
    Fleischauer AT, Simonsen N, Arab L. Antioxidant supplements and risk of breast cancer recurrence and breast cancer–related mortality among postmenopausal women. Nutr Cancer 2003; 46: 1522.
  • 20
    Aziz MH, Kumae R, Ahmad N. Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms. Int J Oncol 2003; 23: 1728.
  • 21
    Sarkar FH, Li Y. Soy isoflavones and cancer prevention. Cancer Invest 2003; 21: 74457.
  • 22
    Selvakumaran M, Pisarcik DA, Bao R, Yeung AT, Hamilton TC. Enhanced cisplatin cytotoxicity by disturbing the nucleotide excision repair pathway in ovarian cancer cell lines. Cancer Res 2003; 63: 13116.
  • 23
    Thor AD, Liu S, Moore DH2nd, Edgerton SM. Comparison of mitotic index, in vitro bromodeoxyuridine labeling, and MIB-1 assays to quantitate proliferation in breast cancer. J Clin Oncol 1999; 17: 4707.
  • 24
    Zhang DY, Wu J, Ye F, Xue L, Jiang S, Yi J, Zhang W, Wei H, Sung M, Wang W, Li X. Inhibition of cancer cell proliferation and prostaglandin E2 synthesis by Scutellaria baicalensis. Cancer Res 2003; 63: 403743.
  • 25
    Maxwell PJ, Longley DB, Latif T, Boyer J, Allen W, Lynch M, McDermott U, Harkin DP, Allegra CJ, Johnston PG. Identification of 5-fluorouracil-inducible target genes using cDNA microarray profiling. Cancer Res 2003; 63: 46026.
  • 26
    Iizuka N, Oka M, Yamamoto K, Tangoku A, Miyamoto K, Miyamoto T, Uchimura S, Hamamoto Y, Okita K. Identification of common or distinct genes related to antitumor activities of a medicinal herb and its major component by oligonucleotide microarray. Int J Cancer 2003; 107: 66672.
  • 27
    Bai S, Zhao Y, Zhang X, Li H, Jing J, Xie C, Chen G. Establishment of a heterologous graft model for human breast infiltrating duct carcinoma in nude mice. Hua Xi Yi Ke Da Xue Xue Bao 1999; 30: 2201.
  • 28
    Chen D, Zhao Y, Bai S, Shi Z, Zhang J. Effect of ginsenoside Rg3 on the progression of orthotopically xenotransplanted human breast cancer in nude mice and its mechanism. Sichuan Da Xue Xue Bao Yi Xue Ban 2003; 34: 5468.
  • 29
    Zhang DY, Wu J, Ye F, Xue L, Jiang S, Yi J, Zhang W, Wei H, Sung M, Wang W, Li X. Inhibition of cancer cell proliferation and prostaglandin E2 synthesis by Scutellaria baicalensis. Cancer Res 2003; 63: 403743.
  • 30
    Duan WR, Garner DS, Williams SD, Funckes-Shippy CL, Spath IS, Blomme EA. Comparison of immunohistochemistry for activated caspase-3 and cleaved cytokeratin 18 with the TUNEL method for quantification of apoptosis in histological sections of PC-3 subcutaneous xenografts. J Pathol 2003; 199: 2218.
  • 31
    Liu Y, Wang X, Liu Y. Protective effects of tanshinone IIA on injured primary cultured rat hepatocytes induced by CCl4. Zhong Yao Cai 2003; 26: 4157.
  • 32
    Liu Chen H, Jiang Y. Protective effect of tanshinone IIA on acute hepatic injury in mice. Zhong Yao Cai 2001; 24: 5889.
  • 33
    Singh AV, Xiao D, Lew KL, Dhir R, Singh SV. Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenografts in vivo. Carcinogenesis 2004; 25: 8390.
  • 34
    Swami S, Raghavachari N, Muller UR, Bao YP, Feldman D. Vitamin D growth inhibition of breast cancer cells: gene expression patterns assessed by cDNA microarray. Breast Cancer Res Treat 2003; 80: 4962.
  • 35
    Milosevic J, Kanazir S, Medic-Mijacevic L, Pejanovic V, Stokic Z, Konjevic G, Rakic L, Ruzdijic S. Sulfinosine-induced cell growth inhibition and apoptosis in human lung carcinomas in vitro. Invest New Drugs 2002; 20: 22940.
  • 36
    Zhang L, Sharma S, Zhu LX, Kogai T, Hershman JM, Brent GA, Dubinett SM, Huang M. Nonradioactive iodide effectively induces apoptosis in genetically modified lung cancer cells. Cancer Res 2003; 63: 506572.
  • 37
    Monks A, Harris E, Hose C, Connelly J, Sausville EA. Genotoxic profiling of MCF-7 breast cancer cell line elucidates gene expression modifications underlying toxicity of the anticancer drug 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole. Mol Pharmacol 2003; 63: 76672.
  • 38
    Xie MJ, Motoo Y, Su SB, Mouri H, Ohtsubo K, Matsubara F, Sawabu N. Expression of clusterin in human pancreatic cancer. Pancreas 2002; 25: 2348.
  • 39
    Hershberger PA, McGuire TF, Yu WD, Zuhowski EG, Schellens JH, Egorin MJ, Trump DL, Johnson CS. Cisplatin potentiates 1,25-dihydroxyvitamin D3-induced apoptosis in association with increased mitogen-activated protein kinase kinase kinase 1 (MEKK-1) expression. Mol Cancer Ther 2002; 1: 8219.
  • 40
    Duxbury MS, Ito H, Benoit E, Waseem T, Ashley SW, Whang EE. A novel role for carcinoembryonic antigen–related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cells. Cancer Res 2004; 64: 398793.
  • 41
    Zeng ZS, Shu WP, Cohen AM, Guillem JG. Matrix metalloproteinase-7 expression in colorectal cancer liver metastases: evidence for involvement of MMP-7 activation in human cancer metastases. Clin Cancer Res 2002; 8: 1448.
  • 42
    Huo N, Ichikawa Y, Kamiyama M, Ishikawa T, Hamaguchi Y, Hasegawa S, Nagashima Y, Miyazaki K, Shimada H. MMP-7 (matrilysin) accelerated growth of human umbilical vein endothelial cells. Cancer Lett 2002; 177: 95100.
  • 43
    Eckel KL, Tentler JJ, Cappetta GJ, Diamond SE, Gutierrez-Hartmann A. The epithelial-specific ETS transcription factor ESX/ESE-1/Elf-3 modulates breast cancer–associated gene expression. DNA Cell Biol 2003; 22: 7994.
  • 44
    Singh S, Barrett J, Sakata K, Tozer RG, Singh G. ETS proteins and MMPs: partners in invasion and metastasis. Curr Drug Targets 2002; 3: 35967.
  • 45
    Griesenbeck J, Oei SL, Mayer-Kuckuk P, Ziegler M, Buchlow G, Schweiger M. Protein–protein interaction of the human poly(ADP-ribosyl)transferase depends on the functional state of the enzyme. Biochemistry 1997; 36: 7297304.
  • 46
    Lockett KL, Hall MC, Xu J, Zheng SL, Berwick M, Chuang SC, Clark PE, Cramer SD, Lohman K, Hu JJ. The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme function. Cancer Res 2004; 64: 63448.
  • 47
    Wang G, Chuang L, Zhang X, Colton S, Dombkowski A, Reiners J, Diakiw A, Xu XS. The initiative role of XPC protein in cisplatin DNA damaging treatment-mediated cell cycle regulation. Nucleic Acids Res 2004; 32: 223140.
  • 48
    Takamura-Enya T, Watanabe M, Totsuka Y, Kanazawa T, Matsushima-Hibiya Y, Koyama K, Sugimura T, Wakabayashi K. Mono(ADP-ribosyl)ation of 2′-deoxyguanosine residue in DNA by an apoptosis-inducing protein, pierisin-1, from cabbage butterfly. Proc Natl Acad Sci USA 2001; 98: 1241419.
  • 49
    Hatip-Al-Khatib I, Iwasaki K, Chung EH, Egashiea N, Mishima K, Fujiwara M. Inhibition of poly(ADP-ribose)polymerase and caspase-3, but not caspase-1, prevents apoptosis and improves spatial memory of rats with twice-repeated cerebral ischemia. Life Sci 2004; 75: 196778.